about
Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestationsEndothelial Dysfunction and Inflammation: Immunity in Rheumatoid ArthritisChemokine Involvement in Fetal and Adult Wound HealingA meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinomaChemokines and microRNAs in atherosclerosisChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesRetinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiationCXCL10 Acts as a Bifunctional Antimicrobial Molecule against Bacillus anthracis.Chemokines as mediators of tumor angiogenesis and neovascularizationIdentification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracisCXC chemokines in cancer angiogenesis and metastasesEarly NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.Chemokines as mediators of neovascularizationIdentification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.Vascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context.Chemotaxis in cancerHigh Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD AlloimmunizationEffect of mini-tyrosyl-tRNA synthetase on ischemic angiogenesis, leukocyte recruitment, and vascular permeabilityChemokines and angiogenesis in rheumatoid arthritis.Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis.The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosisStrategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.CT perfusion can predict overexpression of CXCL8 (interleukin-8) in head and neck squamous cell carcinoma.Aberrant proliferation in CXCR7+ endothelial cells via degradation of the retinoblastoma protein.Engineered three-dimensional microfluidic device for interrogating cell-cell interactions in the tumor microenvironment.Association between preeclampsia and the CXC chemokine family (Review).Targeting chemokine pathways in esophageal adenocarcinoma.Professional antigen presenting cells in human herpesvirus 8 infection.High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.Multiple roles for chemokines in the pathogenesis of SIV infectionChemokines shape the immune responses to tuberculosis.Fractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placentaHeparin and related drugs: beyond anticoagulant activity.Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents.Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.The good and the bad of chemokines/chemokine receptors in melanoma.Exploring the role of CHI3L1 in "pre-metastatic" lungs of mammary tumor-bearing mice.Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?CX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: the importance of CX3CR1 signaling.
P2860
Q21195408-44FA5C5C-9E99-4ADC-AF35-3D44E9560414Q26749294-0D9D0B8B-A6CB-48BE-9717-B316891AE981Q26778688-DE095D60-65A1-4403-A538-018C5E64A0F0Q26800288-70AB0D30-E240-40BC-8F7A-60DC8BD7FA0BQ26852545-CE0F02E7-5ECF-4000-B5EF-9595BEAE2C40Q26866236-5D154D0B-B928-4B31-90D7-0F4266DE9E2BQ28538588-803010B8-4C3C-4E22-A54C-36640BB8EDFFQ30276830-2B349B19-EE20-434A-9AFD-8C58FFA75C77Q30427886-8BC5BD28-E3F1-42B1-B3D8-6036760A7C48Q30430226-EEDCD9A1-D1D6-47E6-AB90-F62D6CEF8BFEQ30432791-E235C79D-2FEB-4E22-8C9E-AD65D103722FQ30433397-5920229F-491A-45E7-B442-E807E55741E9Q30438032-8AA3BB6B-7FC6-475C-8C94-FF7B49CD1445Q30438758-EE6020AB-103F-40DB-A7D1-DE16D28D6A96Q30559386-A7A27CFC-2621-462A-93F4-9413B9C471FBQ30578627-4869B575-8447-407E-9181-88D4D84E97FEQ33863461-8F83DCF6-1CA9-4A26-931D-6FE455FB44F2Q33891425-1A843BC8-CC0E-4593-A3EF-EFC2DE81024DQ33909030-80BACBFE-8D84-45A2-B4A6-8D81B9388ECFQ33999700-C0A15214-7487-49BB-97F2-03E2461C7623Q34226377-D74A9699-10D5-4510-9706-DEA89F399731Q34535086-C6F02387-D285-46F1-B20E-325926A73CF3Q34674982-897D44C2-FE90-4A34-BCC3-922807B4F958Q34729776-C7286ED0-B08F-40B6-AE81-EFAB583EC0D2Q34874678-FFD3BB44-6AE9-44ED-A75B-C0065B780FFDQ35402234-664C55DD-6386-47EC-9D4A-14845FCB2E18Q35753903-F18363F5-9576-49EF-A2AB-D06A982C5F3DQ36187424-FA35391A-0469-4DE0-9A38-8A0D54127D98Q36546999-E5CF0594-2218-4BBC-9392-78DE51A21C88Q36557288-4B606424-2850-4DDD-B68A-6934D2585E8AQ36634172-D7B07560-2538-469D-9C7B-8617658F24C0Q36640097-8CA04641-1493-4103-A47E-F9E0E79F61D0Q37061311-FF8C8204-3BDB-4A37-85BF-C119CACEFFA2Q37105310-4B88295C-B22B-45D0-921A-0110C44026B7Q37124747-E7E53487-532A-42D9-AB55-CF753C708853Q37218723-396A0F25-F77B-4BC4-9D83-4D41412FA2C6Q37394981-0861F35B-8296-4991-8DF0-281CF109BBC5Q37413102-21A7AC97-0C3D-4FC8-9769-A773012D265FQ37453953-C619FB0E-094C-4E58-BD72-8A663A0124C8Q37578508-198CD903-0966-4ACE-806F-B433608584B2
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chemokines as mediators of angiogenesis.
@ast
Chemokines as mediators of angiogenesis.
@en
type
label
Chemokines as mediators of angiogenesis.
@ast
Chemokines as mediators of angiogenesis.
@en
prefLabel
Chemokines as mediators of angiogenesis.
@ast
Chemokines as mediators of angiogenesis.
@en
P356
P1476
Chemokines as mediators of angiogenesis
@en
P2093
Michael P Keane
Robert M Strieter
P304
P356
10.1160/TH07-01-0040
P50
P577
2007-05-01T00:00:00Z